This study aims to study the clinical and pathological features of lung cancerpatients treated at our institute between January 2011 and December 2016. SUBJECTS AND
Of the 446 patients analyzed, 304 (68%) were males and 142 (32%) were females, with the ratio being 21. Most of our patients had a lesion localizing to the right side (45.7%) than left (37.8%). NSCLC was reported in 81.1% of our patients. EGFR mutation was found in 60 (24%) patients, the most common mutation being the deletion of exon 19 (73%) followed by L858R mutation (21.6%).